跳至主要内容
临床试验/TCTR20240429003
TCTR20240429003已完成2 期

Factors enhanced seizure free rate with AMPA receptor antagonist in traumatic brain injury and post-operative brain tumor surgery in neurosurgical intensive care unit.

Phramongkutklao Hospital Foundation0 个研究点目标入组 76 人开始时间: 2024年4月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Drug-resistant focal epilepsy patients over the age of 20 were invited to participate in the study at our Division. Drug-resistant epilepsies are defined as individuals who fail to achieve seizure free despite using two anti-seizure medicines, either polytherapy or sequential monotherapy, and adhering to a strict treatment regimen.

排除标准

  • Patients who refused to fill out questionnaires for the trial were excluded.

研究者

发起方
Phramongkutklao Hospital Foundation

相似试验